Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

E. Giovannetti, R.J. Honeywell, A.R. Hanauske, C. Tekle, B. Kuenen, J. Sigmond, G. Giaccone, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)12-28
JournalCurrent Drug Targets
Volume11
Issue number1
DOIs
Publication statusPublished - 2010

Cite this

Giovannetti, E. ; Honeywell, R.J. ; Hanauske, A.R. ; Tekle, C. ; Kuenen, B. ; Sigmond, J. ; Giaccone, G. ; Peters, G.J. / Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC). In: Current Drug Targets. 2010 ; Vol. 11, No. 1. pp. 12-28.
@article{fc0ee58c230b49f8a94edf9de4fd6c5a,
title = "Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)",
author = "E. Giovannetti and R.J. Honeywell and A.R. Hanauske and C. Tekle and B. Kuenen and J. Sigmond and G. Giaccone and G.J. Peters",
year = "2010",
doi = "10.2174/138945010790031009",
language = "Undefined/Unknown",
volume = "11",
pages = "12--28",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC). / Giovannetti, E.; Honeywell, R.J.; Hanauske, A.R.; Tekle, C.; Kuenen, B.; Sigmond, J.; Giaccone, G.; Peters, G.J.

In: Current Drug Targets, Vol. 11, No. 1, 2010, p. 12-28.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

AU - Giovannetti, E.

AU - Honeywell, R.J.

AU - Hanauske, A.R.

AU - Tekle, C.

AU - Kuenen, B.

AU - Sigmond, J.

AU - Giaccone, G.

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - 10.2174/138945010790031009

DO - 10.2174/138945010790031009

M3 - Article

VL - 11

SP - 12

EP - 28

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 1

ER -